Tes, October 1 ovember 24, 2009. Washington D.C: CDC - Centers for Disease

Матеріал з HistoryPedia
Версія від 17:51, 26 січня 2018, створена Steven1chime (обговореннявнесок) (Створена сторінка: Simonsen KA, Hunskaar S, [http://www.medchemexpress.com/5-BrdU.html 5-BrdU biological activity] Wensaas KA, R tveit S, Cox R, Nj stad G, et al. Pandemic influen...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

Simonsen KA, Hunskaar S, 5-BrdU biological activity Wensaas KA, R tveit S, Cox R, Nj stad G, et al. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis. 2014;14(3):227?8. 16. WHO. WHO recommendations on pandemic (H1N1) 2009 vaccines, Pandemic (H1N1) 2009 briefing note two. Geneva: Globe Well being Organization; 2009. Accessible from: http://www.who.int/csr/disease/swineflu/notes/h1n1_ vaccine_20090713/en/ [cited 2014 24.04.].Carlsen and Glenton BMC Wellness Solutions Research (2016) 16:Page 14 of17. Racine T. 2009 influenza a/H1N1 mass vaccination tactic: a multinational comparison: national collaborating centre for infectious diseases. 2012. 18. V seda S, Restrepo MA, Arranz E, Mag -Tapia P, Fern dez-Ruiz M, de la C ara AG, et al. Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes amongst health-care workers in a Spanish University Hospital. Vaccine. 2010;28(30):4751?. 19. Lau JTF, Yeung NCY, Choi KC, Cheng MYM, title= j.neuron.2016.04.018 Tsui HY, Griffiths S. Elements in association with acceptability of A/H1N1 vaccination in the course of the influenza A/H1N1 pandemic phase inside the Hong Kong general population. Vaccine. 2010;28(29):4632?. 20. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K. The Public's response to the 2009 H1N1 influenza pandemic. N Engl J Med. 2010;362(22), e65. 21. Velan B, Kaplan G, Ziv A, Boyko V, Lerner-Geva L. Main motives in non-acceptance of A/H1N1 flu vaccination: The weight of rational assessment. Vaccine. 2011;29(6):1173?. 22. Taha SA, Matheson K, Anisman H. The 2009 H1N1 influenza pandemic: the part of threat, coping, and media trust on vaccination intentions in Canada. J Health Commun. 2013;18(three):278?0. 23. Blasi F, Aliberti S, Mantero M, Centanni S. Compliance with anti-H1N1 vaccine amongst healthcare workers and general population. Clin Microbiol Infect. 2012;18:37?1. 24. S chez-Pay?J, Hern dez-Garc I, Garc -Rom V, Camargo-Angeles R, Barrenengoa-Sa do J, Villanueva-Ruiz CO, et al. Influenza vaccination among healthcare personnel just after pandemic influenza H1N1. Vaccine. 2012; 30(five):911?. 25. Sakaguchi S, Weitzner B, Carey N, Bozzo P, Mirdamadi K, Samuel N, et al. Pregnant women's perception of threat with use with the H1N1 vaccine. J Obstet Gynaecol Can. 2011;33(five):460?. 26. Yang ZJ. Also scared or as well capable? Why Do college students keep away from the H1N1 vaccine? Danger title= journal.pone.0111391 Anal. 2012;32(10):1703?6. 27. Sasaki TK, Yoshida A, Kotake K. Attitudes concerning the 2009 h1n1 influenza pandemic amongst pregnant Japanese females along with the use on the Japanese municipality as a source of details. Southeast Asian J Trop Med Public Health. 2013;44(three):388?9. 28. Opstelten W, van Essen GA, Heijnen ML, Ballieux MJP, Goudswaard AN. Higher vaccination prices for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch common practice. Vaccine. 2010; 28(38):6164?. 29. Simonsen KA, Hunskaar S, Wensaas KA, R tveit S, Cox R, Nj stad G, et al. Influenza-like illness in Norway: clinical course, attitudes towards vaccination and preventive measures for the duration of the 2009 pandemic. Household Pract. 2012; 29(2):139?six. 30.